Theresa L. Werner, MD, of the Huntsman Cancer Institute at the University of Utah, talks about why immunotherapy is not a mainstay of treatment for ovarian cancer as it is with other solid tumors, and where this therapy stands when it comes to gynecologic malignancies.
jnccn360.org